Tzeng Wen-Sheng, Wu Reng-Hong, Lin Ching-Yih, Chen Jyh-Jou, Sheu Ming-Juen, Koay Lok-Beng, Lee Chuan
Department of Radiology, Chi-Mei Foundation Medical Center, Tainan, Taiwan.
Korean J Radiol. 2009 Sep-Oct;10(5):481-9. doi: 10.3348/kjr.2009.10.5.481. Epub 2009 Aug 25.
This study was designed to determine if existing methods of grading liver function that have been developed in non-Asian patients with cirrhosis can be used to predict mortality in Asian patients treated for refractory variceal hemorrhage by the use of the transjugular intrahepatic portosystemic shunt (TIPS) procedure.
Data for 107 consecutive patients who underwent an emergency TIPS procedure were retrospectively analyzed. Acute physiology and chronic health evaluation (APACHE II), Child-Pugh and model for end-stage liver disease (MELD) scores were calculated. Survival analyses were performed to evaluate the ability of the various models to predict 30-day, 60-day and 360-day mortality. The ability of stratified APACHE II, Child-Pugh, and MELD scores to predict survival was assessed by the use of Kaplan-Meier analysis with the log-rank test.
No patient died during the TIPS procedure, but 82 patients died during the follow-up period. Thirty patients died within 30 days after the TIPS procedure; 37 patients died within 60 days and 53 patients died within 360 days. Univariate analysis indicated that hepatorenal syndrome, use of inotropic agents and mechanical ventilation were associated with elevated 30-day mortality (p < 0.05). Multivariate analysis showed that a Child-Pugh score > 11 or an MELD score > 20 predicted increased risk of death at 30, 60 and 360 days (p < 0.05). APACHE II scores could only predict mortality at 360 days (p < 0.05).
A Child-Pugh score > 11 or an MELD score > 20 are predictive of mortality in Asian patients with refractory variceal hemorrhage treated with the TIPS procedure. An APACHE II score is not predictive of early mortality in this patient population.
本研究旨在确定在非亚洲肝硬化患者中开发的现有肝功能分级方法,是否可用于预测接受经颈静脉肝内门体分流术(TIPS)治疗难治性静脉曲张出血的亚洲患者的死亡率。
对107例连续接受急诊TIPS手术的患者的数据进行回顾性分析。计算急性生理与慢性健康状况评估(APACHE II)、Child-Pugh评分和终末期肝病模型(MELD)评分。进行生存分析以评估各种模型预测30天、60天和360天死亡率的能力。通过使用对数秩检验的Kaplan-Meier分析评估分层的APACHE II、Child-Pugh和MELD评分预测生存的能力。
在TIPS手术期间无患者死亡,但82例患者在随访期间死亡。30例患者在TIPS手术后30天内死亡;37例患者在60天内死亡,53例患者在360天内死亡。单因素分析表明,肝肾综合征、使用血管活性药物和机械通气与30天死亡率升高相关(p<0.05)。多因素分析显示,Child-Pugh评分>11或MELD评分>20预测30天、60天和360天死亡风险增加(p<0.05)。APACHE II评分仅能预测360天的死亡率(p<0.05)。
Child-Pugh评分>11或MELD评分>20可预测接受TIPS手术治疗的亚洲难治性静脉曲张出血患者的死亡率。APACHE II评分不能预测该患者群体的早期死亡率。